When does a paclitaxel patent expire?
Paclitaxel does not have a single, simple “one date” patent expiry. Paclitaxel products have been protected by many different patents over time, including patents tied to the drug substance, formulation, and specific commercial products. Expiry dates therefore depend on which exact paclitaxel brand or product (and which patent family) you mean.
DrugPatentWatch.com tracks patent and exclusivity information by drug product and is a practical starting point for pinpointing the relevant expiry dates for the specific paclitaxel product you’re researching. [1]
What paclitaxel product are you looking at (and why it changes the expiry date)?
The paclitaxel landscape differs by product, because companies can get additional patent coverage for things like:
- the formulation (for example, solvent systems and delivery technology),
- dosing or manufacturing processes,
- combination indications, and
- specific package/strength presentations.
So “paclitaxel patent expiry” can mean very different dates depending on whether you mean:
- generic paclitaxel vs branded paclitaxel,
- paclitaxel in a particular injectable formulation, or
- paclitaxel-containing combination therapies.
If you share the brand name (or strength/form), the expiry date you want can be narrowed to the correct patent family.
How can you find the exact expiry date you need?
To get the correct “expiry” figure, you usually need to match the patent listing to:
- the specific paclitaxel product you care about, and
- whether you’re asking about patent expiry (legal patent term) versus exclusivity (regulatory exclusivity rules).
A product-by-product approach is what DrugPatentWatch.com supports. [1]
Where do patents and “exclusivity” differ for paclitaxel?
Patent expiry and regulatory exclusivity don’t always line up. A brand may lose patent protection but still have some form of regulatory exclusivity (or vice versa), which affects when competitors can launch.
For paclitaxel, this again varies by product and patent family, so the right answer depends on the exact product you’re targeting. [1]
Source
- https://www.drugpatentwatch.com/